1,2,4-OXADIAZOLE COMPOUNDS, PREPARATION METHOD THEREFOR AND MEDICINAL USE THEREOF
The present invention relates to 1,2,4-oxadiazole compounds, a preparation method therefor and a use thereof, and in particular, to a compound represented by a general formula (I), a preparation method therefor, a pharmaceutical composition comprising the compound, and a use of the compound as a Far...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
30.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to 1,2,4-oxadiazole compounds, a preparation method therefor and a use thereof, and in particular, to a compound represented by a general formula (I), a preparation method therefor, a pharmaceutical composition comprising the compound, and a use of the compound as a Farnesoid X receptor (FXR) agonist. The compound and the pharmaceutical composition comprising the compound can be used for treating and/or preventing diseases related to the activity of the FXR such as cholestasis, diabetes and complications thereof, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), obesity or metabolic syndrome (dyslipidemia, diabetes, and complications having an abnormally high body mass index), and cardiovascular disease. The definition of each substituent in the general formula (I) is the same as that in the description.
涉及1,2,4-噁二唑类化合物及其制备方法和医药用途,特别涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物,及其作为法尼醇衍生物X受体(Farnesoid X receptor,FXR)激动剂的用途,该化合物及含有该化合物的药物组合物可以用于治疗和/或预防与FXR活性相关的疾病 |
---|---|
AbstractList | The present invention relates to 1,2,4-oxadiazole compounds, a preparation method therefor and a use thereof, and in particular, to a compound represented by a general formula (I), a preparation method therefor, a pharmaceutical composition comprising the compound, and a use of the compound as a Farnesoid X receptor (FXR) agonist. The compound and the pharmaceutical composition comprising the compound can be used for treating and/or preventing diseases related to the activity of the FXR such as cholestasis, diabetes and complications thereof, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), obesity or metabolic syndrome (dyslipidemia, diabetes, and complications having an abnormally high body mass index), and cardiovascular disease. The definition of each substituent in the general formula (I) is the same as that in the description.
涉及1,2,4-噁二唑类化合物及其制备方法和医药用途,特别涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物,及其作为法尼醇衍生物X受体(Farnesoid X receptor,FXR)激动剂的用途,该化合物及含有该化合物的药物组合物可以用于治疗和/或预防与FXR活性相关的疾病 |
Author | YAN XU YIN HUIJUN LIU CHUNYAN MI ZHEN WANG BIN ZONG LIBIN SHI JIANXIN SI CHUNFENG |
Author_xml | – fullname: YIN HUIJUN – fullname: SHI JIANXIN – fullname: ZONG LIBIN – fullname: SI CHUNFENG – fullname: LIU CHUNYAN – fullname: YAN XU – fullname: MI ZHEN – fullname: WANG BIN |
BookMark | eNrjYmDJy89L5WQINNQx0jHR9Y9wdPF0jPL3cVVw9vcN8A_1cwnWUQgIcg1wDHIM8fT3U_B1DfHwd1EI8XANcnXzD1Jw9HMBirl4Onv6OfoohAa7QqT83XgYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbyzn6GhoYWZhYGpmaMxMWoAj9Iwpg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 1,2,4-噁二唑类化合物及其制备方法和医药用途 |
ExternalDocumentID | CN111868056A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN111868056A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:45:43 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN111868056A3 |
Notes | Application Number: CN201980018242 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201030&DB=EPODOC&CC=CN&NR=111868056A |
ParticipantIDs | epo_espacenet_CN111868056A |
PublicationCentury | 2000 |
PublicationDate | 20201030 |
PublicationDateYYYYMMDD | 2020-10-30 |
PublicationDate_xml | – month: 10 year: 2020 text: 20201030 day: 30 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | THE NATIONAL INSTITUTES OF PHARMACEUTICAL RES AND DEVELOPMENT NIP |
RelatedCompanies_xml | – name: THE NATIONAL INSTITUTES OF PHARMACEUTICAL RES AND DEVELOPMENT NIP |
Score | 3.4252455 |
Snippet | The present invention relates to 1,2,4-oxadiazole compounds, a preparation method therefor and a use thereof, and in particular, to a compound represented by a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | 1,2,4-OXADIAZOLE COMPOUNDS, PREPARATION METHOD THEREFOR AND MEDICINAL USE THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201030&DB=EPODOC&locale=&CC=CN&NR=111868056A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUaP4kZqYPbHIRse2h8WMtsswbJ0wDPGF2LFFfQAiMyb-9XYDxBd9a3rJpf21d9fr9a4AN5Yw7TTFupqaGlZxatqqkFZHtY1Ub00wNuykSBQOwrY_xPcjY1SBt3UuTFkn9LMsjiglKpHynpf6er65xKLl28rFrXiVXbM7L3aosvKOi9Buq6nQjsMiTjlRCHFIqIR9R4q01baktXe3YLs4Rhd19tljp8hKmf82Kd4B7ESS2zQ_hMrXSw32yPrntRrsBquAt2yuZG9xBA9aQ29glY9c2nWfeI8hwoOID0M6aCAJZOQu75tQwGKfUxT7rM-kj4fckKKyimM3dHtoOGBLEveO4dpjMfFVObbxDxBjEm6m0TqB6nQ2TU8BZZk50SZ6YjwnAmembWmGXBchMrlLMtG0zqD-N5_6f8Rz2C9ALXV18wKq-ftHeimNcC6uSvS-AQschNo |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8UjfimqFH8qonZE4tsdGx7WMxouwzd2gnDEF-IHVvUByAyY-JfbzdAfNG3ppdc2mvvLnfX-xWAa0uYdpoiXU1NDakoNW1VSK-j2kaqt8YIGXZSNAqHrO0P0N3QGG6At1UvTIkT-lmCI0qNSqS-56W9nq2TWKR8Wzm_Ea9yanrrxQ5RltFxUdptNRXScWjECccKxg5mCus5UqWttiW9vbsJtkwZEhY4-_SxU3SlzH67FG8PbEeS2yTfBxtfLzVQxauf12pgJ1wWvOVwqXvzA_CgNfQGUvnQJV33iQcUYh5GfMBIvwGlICN3kW-CIY19TmDs0x6VMR50GYElimOXuQEc9OmCxL1DcOXRGPuqXNvoRxAjzNbbaB2BymQ6SY8BzDJzrI31xHhOBMpM29IMeS5CZPKWZKJpnYD633zq_xEvQdWPw2AUdNn9KdgtBFza7eYZqOTvH-m5dMi5uCgl-Q1oO4fF |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=1%2C2%2C4-OXADIAZOLE+COMPOUNDS%2C+PREPARATION+METHOD+THEREFOR+AND+MEDICINAL+USE+THEREOF&rft.inventor=YIN+HUIJUN&rft.inventor=SHI+JIANXIN&rft.inventor=ZONG+LIBIN&rft.inventor=SI+CHUNFENG&rft.inventor=LIU+CHUNYAN&rft.inventor=YAN+XU&rft.inventor=MI+ZHEN&rft.inventor=WANG+BIN&rft.date=2020-10-30&rft.externalDBID=A&rft.externalDocID=CN111868056A |